Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Stacey McCullough"'
Autor:
Stacey McCullough, George Arrowsmith, Aaron J. Lyss, Stephen M. Schleicher, Natalie R. Dickson, Garrett Young, Edward Arrowsmith
Publikováno v:
Journal of Clinical Oncology. 38:248-248
248 Background: Guidelines support the use of prophylactic antivirals to prevent reactivation of herpes varicella in patients with multiple myeloma (MM) on proteasome inhibitors (PI). In our network of five oncology practices spanning over 100 clinic
Autor:
Sylvia S. Richey, Garrett Young, Edward Arrowsmith, Natalie R. Dickson, Lee S. Schwartzberg, Johnetta Blakely, Stephen M. Schleicher, Stacey McCullough
Publikováno v:
Journal of Clinical Oncology. 38:253-253
253 Background: Prophylaxis for highly emetogenic chemotherapy (HEC) is well established in clinical guidelines, but real-world treatment patterns are unclear. Today, consistent use of prophylaxis is more easily accomplished due to the incorporation
Autor:
Rachel L. Mitchell, Stephen M. Schleicher, Tennessee Oncology, Natalie R. Dickson, Stacey McCullough, Jack L. Taylor, Edward Arrowsmith
Publikováno v:
Journal of Clinical Oncology. 38:226-226
226 Background: Uninterrupted utilization of oral oncolytics is critical to maximizing safety and efficacy of cancer treatment. The COVID-19 pandemic presented numerous challenges to delivering a continuous and safe supply of oral oncolytics to patie
Autor:
Natalie R. Dickson, Edward Arrowsmith, Jack L. Taylor, Stacey McCullough, Stephen M. Schleicher, Rachel L. Mitchell
Publikováno v:
Journal of Clinical Oncology. 38:102-102
102 Background: Dependable and timely dispensing and delivery of oral oncolytics to patients with a new indication for therapy is a central part of modern cancer care. The COVID-19 pandemic has presented numerous impediments and challenges to patient
Autor:
Garrett Young, Stephen M. Schleicher, Stacey McCullough, Aaron J. Lyss, Mary Catherine Marsden, Edward Arrowsmith, Natalie R. Dickson, Stacey L Poole, Kathy McGee, Lee S. Schwartzberg, Leah Owens, Sylvia S. Richey
Publikováno v:
Journal of Clinical Oncology. 38:9-9
9 Background: The use of biosimilar drugs in the treatment of cancer offer an opportunity for oncology providers to decrease total cost of care while preserving quality. However, it remains unclear whether providers and patients may resist biosimilar
Autor:
Stacey McCullough
Publikováno v:
Cancer therapy & Oncology International Journal. 11
Autor:
Stacey, McCullough, Ricky, Newton
Publikováno v:
The American journal of managed care. 23(12 Spec)
Autor:
Jared Crumb, Susan A Frailley, Leah Owens, Jack L. Taylor, N. W. Peacock, Kimberly Senneke, Jeffrey Patton, Edward Arrowsmith, Aaron J. Lyss, Stacey McCullough, Carolyn J. Kelsey, Laura Kaufman
Publikováno v:
Journal of Clinical Oncology. 37:260-260
260 Background: The growing number of oral oncolytic therapies (OOTs) necessitates a standardized EMR workflow that integrates pharmacy activities for dispense and patient management and standardizes cycle-1/day-1 (C1D1) documentation. Our practice
Publikováno v:
Community Oncology. 10:306-308